Focus area
Therapeutics Investment Firms
The RaiseHunt database lists 869 Therapeutics investment firms: 862 of them list a portfolio, 8,149 known investments between them and 4,896 people at those firms have a profile here. Most list Seed and Series A among the rounds they take part in; the largest concentrations are in San Francisco, New York and Boston.
- 869
- Investment firms
- 862
- With a known portfolio
- 8,149
- Known investments
- 4,896
- People with a profile
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
869 Therapeutics investment firms
Showing 1-20
Filters
| Firm | Location | Type | Markets | Contact | Actions |
|---|---|---|---|---|---|
GV Genesis Ventures | Chile | Syndicate / Angel groupVenture capital | AIClimate | View fund | |
NP Next Play Ventures | San Francisco, United States | Venture capital | AICommerce | View fund | |
MF MiraeAsset Financial Group | New York, United States | Private equityVenture capital | AIFinTech | View fund | |
M Morningside | Boston, United States | Private equityVenture capital | AIFinTech | View fund | |
ER Eight Roads | London, United Kingdom | Venture capital | AICommerce | View fund | |
SG Shanda Group | Shanghai, China | Family OfficePrivate equity | AIConsumer | View fund | |
BI BioInnovation Institute (BII) | Copenhagen, Denmark | Accelerator | ClimateFood | View fund | |
SP Signal Peak Ventures | Salt Lake City, United States | Private equityVenture capital | AIClimate | View fund | |
HC Highlight Capital | Shanghai, China | Venture capital | AIHardware | View fund | |
MV Maverick Ventures | San Francisco, United States | Venture capitalVenture debt | AICommerce | View fund | |
N NewSpring | Philadelphia, United States | Private equityVenture debt | AICommerce | View fund | |
AC Advantage Capital | New Orleans, United States | Private equityVenture debt | ClimateConsumer | View fund | |
H HealthCap | Stockholm, Sweden | Venture capital | FinTechHealthcare | View fund | |
FD Fonds de solidarité FTQ | Montreal, Canada | Private equityVenture capital | AIClimate | View fund | |
IV IU Ventures | Indianapolis, United States | Syndicate / Angel group | AIConsumer | View fund | |
CC CD Capital | Shanghai, China | Private equityVenture capital | HardwareHealthcare | View fund | |
WV Wisdom Ventures | Palo Alto, United States | Venture capital | AICommerce | View fund | |
A/ AbbVie / AbbVie Ventures | Chicago, United States | Corporate VC | Healthcare | View fund | |
BC Brandon Capital | Melbourne, Australia | Venture capital | Healthcare | View fund | |
GC GP Capital Co. | Shanghai, China | Private equity | AIFinTech | View fund |
829 of 869 Therapeutics investment firms, A to Z
Grouped by first letter. Name and profile link only, the detailed rows are in the table above.ShowHide
A77
- Aarin Capital
- AbCellera
- Abingworth
- ABio-X
- Able Partners
- ABS Ventures
- Abu Dhabi Investment Authority (ADIA)
- Accelerator Ventures
- Achieve Partners
- Ackermans & van Haaren
- Actium Group
- Acumen America
- Adage Capital Management
- Adams Street Partners
- Adaptive Capital Partners
- AdBio partners
- Aditum Bio
- Adq
- Advanced Technology Ventures
- Advent-morro Equity Partners
- Ag Startup Engine
- AGC Equity Partners
- Age1
- AgeChem Financial Inc. (AgeChem / AgeChem Venture Fund)
- Agent Capital
- Ahren Innovation Capital
- Aisling Capital
- Ajax Health
- AJU IB INVESTMENT
- Albacore Capital
- Aliment Capital
- Allied Minds
- Alpha Associates
- ALSA Ventures
- Alta Partners
- Altara Ventures
- Altitude Life Science Ventures
- Altitude Ventures
- Altus Capital Partners
- Ambria Capital
- Amino Collective
- aMoon Fund
- Amplitude Ventures
- Amr Action Fund
- Amundi Private Equity Funds
- Amzak Capital Management
- Amzak Health Investors
- Anaxago
- Andera Partners
- Angelini Ventures
- Animal Health Angels
- Ann Arbor Angels
- Apax
- Apeiron Investment Group
- Apposite Capital
- Aravis SA
- ARCH Venture Partners
- Ardian
- Aristagora Venture Capital
- Arizona Tech Investors
- Artiman Ventures
- ARTIS
- Asabys Partners
- Asahi Kasei
- Asset Management Company
- Atem Capital Fund
- Athenian Venture Partners
- Athos Capital
- Atlas Venture
- ATW Partners
- August One
- Auriga Partners
- AV8 Ventures
- Avalon Bioventures
- Avestria Ventures
- Avidity Partners
- AVP | Advance Venture Partners
B53
- BACKED VC
- Ballast Point Partners
- Baruch Future Ventures
- Bay City Capital
- Bayern Kapital
- Beach Point Capital Management
- BeiGene
- Ben Franklin Technology Partners
- Berkeley Frontier Fund
- Beta Fund
- Beta Lab
- Bgv (biogeneration Ventures)
- Bija Ventures
- Biogen
- BioMark Capital
- BioMedPartners
- Bioqube Ventures
- Biosciences Research & Commercialization Center
- BioVentures Investors
- Bioverge Ventures
- Biovision Ventures
- Black Diamond Ventures (BDV)
- Black Point Group
- BlackRock Private Equity Partners
- Blindspot Ventures
- Blisce/
- Blue Heron Capital
- Blue Pool Capital
- Bluestem Capital
- BlueTree Venture Fund
- Bm-t Beteiligungsmanagement Thüringen
- bmp Ventures
- Bocom International
- Boehringer Ingelheim
- Boehringer Ingelheim Venture Fund
- Boğaziçi Ventures
- Bold Capital
- Boldcap Ventures
- Boot64 Ventures
- Boston Harbor Angels
- Boston Scientific
- BoxOne Ventures
- Boyuan Capital
- Bpd Partners
- Bpea
- Braavos Investment Advisers
- Brace Pharma Capital
- Brightstone Venture Capital
- Bristol Myers Squibb
- British Patient Capital
- BRV Capital Management
- BVM Capital
- BVP (Brightlands Venture Partners)
C68
- C-Bridge Capital
- California Technology Ventures
- Cambrian Bio
- Cambridge Innovation Capital
- Camden Partners
- Camford Capital
- Canaan
- Canaan Partners’ Axcelius
- Cancer Focus Fund
- Cantos
- Capital Dimensions
- Capital Grand Est
- Carao Ventures
- Carlyle AlpInvest
- Carolina Angel Network
- Catalys Pacific
- Catalyst Investors
- Catalytic Impact Foundation
- Cenova
- Centenara Labs
- Centerbridge Partners
- Centers for Disease Control and Prevention
- Central Texas Angel Network
- CFH Management
- Chalmers Ventures
- Charlesbank Capital Partners
- Chemical Angel Network
- Cherrystone Angel Group
- China Merchants Group
- China Singapore Suzhou Industrial Park Ventures
- Chr. Augustinus Fabrikker
- Chugai Venture Fund (CVF)
- CID Capital
- Citadel
- Civilization Ventures
- Cj Investment
- Claris Ventures
- ClearPoint Investment Partners
- CLI Ventures
- CLSA
- Cobalt Ventures
- Coinvest Capital
- Collage Partners
- COLUMBUS VENTURE PARTNERS,S.G.E.I.C.
- Commonweal Ventures
- Concord Health Partners
- Conexo Ventures
- Conscience VC
- Convergence Partners
- Cormorant Asset Management
- Cornell University
- Corner Ventures
- Correlation Ventures
- Corundum Systems Biology
- Corvus Ventures
- Cosine
- Cottonwood Technology Fund
- CRB InverbÃo
- Crédit Mutuel Innovation
- Credit Suisse Entrepreneur Capital
- Crescera Capital
- Cs Capital
- CTI Life Sciences Fund
- Cultivation Capital Life Sciences
- Cure Ventures
- CureDuchenne Ventures
- Curie Capital
- Curie.Bio
D29
- Dalus Capital
- DaVita Venture Group
- DC Capital Partners Management
- DC Investment Partners
- DCVC Bio
- Debiopharm Group
- Decheng Capital
- Deep Insight
- Deep Science Ventures
- DeepWork Capital
- DEFTA Partners
- Delaware Crossing Investor Group
- Delphi Ventures
- Desert Angels
- Development Bank Of Wales
- Digital Healthcare Partners
- Digitx Partners
- DIMENSION
- Dolby Family Ventures
- Drads Capital
- Draper Triangle
- Dreavent
- Droia Ventures
- dRx Capital
- Ds Asset Management
- Dsc Investment
- DSW Ventures
- Duchenne UK
- Duquesne Family Office
E29
- Eagle Ventures
- EcoR1 Capital
- EDBI Pte
- Efung Capital
- Eir Ventures
- Eisai Innovation
- Eksim Ventures
- Elikon Venture
- Elron Ventures
- Emerson Collective
- Emmeline Ventures
- Empath Ventures
- Enavate Sciences
- Endurance28
- Engine Ventures
- Enterprise Partners
- Envisioning Partners
- Eos
- Epic Angels
- Epidarex Capital
- EQT Group (EQT Life Sciences)
- Eqt Life Sciences
- EquityPitcher Ventures
- EQx Fund
- Essential Capital
- ET Capital
- Eurazeo
- Eventide Management Partners
- EVX Ventures
F29
- F-Prime
- F-Prime Capital
- FACIT
- Farallon Capital Management
- Fast Track Initiative
- FemHealth Ventures
- Femsa Ventures
- Fifth Down Capital
- Fink Family Office
- FinTech Innovation Lab
- FIRST
- First In Ventures
- First Spark Ventures
- Flagship Pioneering
- Flerie Invest
- Fletcher Spaght
- Fondazione Social Venture Giordano Dell'amore
- Foresite Capital
- Fortunis Capital
- Forty51 Ventures
- Fosun Pharma
- FPV Ventures
- Freeflow Ventures
- Frist Cressey Ventures
- Front Porch Venture Partners
- Frontier Angels
- Future Planet Capital
- Futurex Capital
- FUTURX
G23
- G9 Ventures
- GBS Ventures
- GE HealthCare
- GED Ventures Portugal
- Genesis Capital Management
- Genesys Capital
- Genoa Ventures
- Georgia Research Alliance
- Gilde Healthcare
- Glengary Ventures
- Global Bio Fund
- Golden Seeds
- Good Growth Capital
- GOOSE Capital
- Gore Range Capital
- GreatPoint Ventures
- Green Arrow Capital
- Greybird Ventures
- Groove Capital
- Growth Box Ventures
- GSK
- Gurnet Point Capital
- GV (Google Ventures)
H30
- H.I.G. Capital
- Hadean Ventures
- HanAll Biopharma
- Hanne Capital
- Harmonix Fund
- Hartbeat Ventures
- Hatteras Venture Partners
- HBM Partners
- HBS Alumni Angels of Greater New York
- Health Enterprise Partners
- Health Innovations
- Health Velocity Capital
- HealthCare Ventures
- Healthspan Capital
- Healthworx
- Helena
- Helicase Venture
- Heliconia Capital Management
- Hercules Capital
- Heron Capital
- Hg Initiative
- Hibiscus Capital Management
- Hikma Ventures
- HIP
- HOF Capital
- Hony Capital
- Horizon Technology Finance
- HT Investment
- Humboldt Fund
- Hunniwell Lake Ventures
I34
- i&i Biotech Fund
- i2E
- IAB - Italian Angels for Biotech
- iGlobe Partners
- IKJ Capital
- Illinois Ventures
- Illumina Ventures
- Impact America Fund
- Impact Engine
- INCE Capital
- InCube Ventures
- Indaco Venture Partners
- Índico Capital Partners
- IndieBio
- Innovating Capital
- Innovation Fund Denmark
- Innovationquarter
- InnovationsKapital
- Intermediate Capital Group
- Intermountain Ventures
- Intersouth Partners
- InterWest Partners
- Intuitive Ventures
- Inventages Venture Capital Investment
- Inveready
- Inveready Technology Investment Group
- Investissement Québec
- Investor AB (investor-ab)
- INVESTSUD
- IronGate Capital Advisors
- iSelect Fund
- Israel Biotech Fund
- ITOCHU Technology Ventures
- IXO PRIVATE EQUITY
J9
- J.p. Morgan Asset Management
- JAZZ Venture Partners
- JEITO
- JLS Fund
- Jmcr Partners
- Jumpspeed Ventures
- Juvenescence
- Juxtapose
- JW Pharmaceuticals
K23
- K2 HealthVentures
- K2 Venture Capital
- K20 Fund
- Kainova Therapeutics
- Kairos Ventures
- Karista
- Kayne Anderson Capital Advisors
- Kb Investment
- KB Securities
- KCK Medtech
- Kdb Investment
- Kearny Venture Partners
- Keiretsu Capital
- Keiretsu Forum
- Kendall Capital Partners
- Ki Tua Fund
- Kineticos Disruptor Fund
- Knight Capital
- Koch Disruptive Technologies
- Kurma Partners
- Kyoto University Innovation Capital
- Kyowa Kirin
- Kyto Technology and Life Science
L27
- Lansdowne Partners
- Lanting Capital
- Launchpad Venture Group
- Lauxera Capital Partners
- LBBW Venture Capital
- LBO France
- Leaps by Bayer
- Leonard Green & Partners (LGP)
- Lichtsteiner Foundation
- Life Sciences Greenhouse Of Pennsylvania
- LifeArc Ventures
- Lifeforce Capital
- Lifelink Ventures
- Lifesci Venture Partners
- Lightstone Ventures
- Linden Capital Partners
- Logos Global Management
- LongeVC
- LongevityTech.fund
- LongGame Ventures
- Longitude Capital
- LongRiver Investments
- Loyal Valley Capital
- Lucas Venture Group
- Lumira Ventures
- LYVC
- LYZZ CAPITAL
M46
- M Venture Partners (MVP)
- Madryn Asset Management
- Magnetar
- Magnetic Ventures
- Maine Venture Fund
- MaRS Discovery District
- Martlet Capital
- Mason Wells
- Maxpro Ventures
- MBG Baden Wuerttemberg
- McCarthy Capital
- McKesson Ventures
- MEDA Angels
- Medicxi
- Medivate Partners
- Meneldor
- Merieux Equity Partners
- Merifin Capital
- Metalmark Capital
- Metrodora Ventures
- MidCap Financial
- Milano Investment Partners SGR
- Milkbox Partners
- Millennium
- Mirae Asset Capital
- Mission BioCapital
- Mithril Capital Management
- Moderna
- Monograph Capital
- Moonfire
- Moore Venture Partners
- Morgenthaler
- MorphoSys
- Mountain Group Partners
- MP Healthcare Venture Management
- MPM BioImpact
- MPower Partners
- Msa Capital
- Mubadala Capital
- Muirwoods Ventures
- Murex Partners
- Muse Capital
- Mutual Capital Partners
- MVM Life Science Partners
- MVP Capital Partners
- MYSC
N28
- Namier Capital Partners
- Nara Capital
- Nationwide Children's Hospital
- Natural Capital
- Navis Capital Partners
- Necessary Ventures
- Negev Capital
- New Markets Venture Partners
- New Mountain Capital
- New Science Ventures
- NEWTON BIOCAPITAL
- Nextech Invest
- NextLeap Ventures
- NGN Capital
- NH Investment & Securities
- Nina Capital
- Nivelinvest
- Noetic Fund
- Nolan Capital
- North Castle Partners
- Northleaf Capital Partners
- Northpond Ventures
- Novartis Venture Fund
- Novateur Ventures
- Nowture
- NuFund Venture Group
- NV Industriebank LIOF
- NYBC Ventures
O21
- Oberland Capital
- Obvious Ventures
- Occident
- Ocean Azul Partners
- OCV
- Olive Tree Capital
- Omega Funds
- Omnes
- OMX Ventures
- OneVentures
- OpAmp Capital
- Operator Collective 🔆
- Optum Ventures
- Orange Grove Bio
- OrbiMed
- ORI Capital
- Oriza Ventures
- Orlando Health
- Osage University Partners (OUP)
- OUTSIZED VENTURES
- Overton Venture Capital
P41
- Pacezero Capital Partners
- PAG
- Palo Santo
- Panacea Capital
- Panakes Partners
- Panorama Capital
- Pappas Capital
- Pappas Capital (Pappas Ventures)
- Paramark Ventures
- Paratus Investment
- Partners Group
- Partners Investment
- Patient Square Capital
- PBM Capital Group
- Perceptive Advisors
- Persephoni Bio
- PGV
- Pharmakon Advisors
- Photon Fund
- Pine Street Capital Partners
- Ping An Ventures
- Pivotal bioVenture Partners
- Pivotal Life Sciences
- Plains Ventures
- Playground Global
- Plutus Investment Group
- PMV
- Point72
- Polaris Partners
- Polytechnique Ventures
- Pontifax Venture Capital
- Population Health Partners
- Premji Invest
- Presidio Partners
- Primera Capital
- Prolog Ventures
- Ptv Healthcare Capital
- Puma Venture Capital
- Pureos Bioventures
- PureTech Health
- Purple Orange Ventures
Q12
- Qatar Investment Authority
- Qbic Fund | Venture Capital
- Qiming Venture Partners
- Qiming Venture Partners USA
- quadraScope
- Quadrille Capital
- Quaker Partners
- Quan Capital
- Quantum Ventures Korea
- Quark Venture
- Queen City Angels
- Qumra Capital
R32
- RA Capital Management
- Rabo Investments
- Rachel Zoe Ventures
- re.Mind
- Recharge Capital
- Red Apple Group
- Red Cell Partners
- Redhill Capital
- Redmile Group
- Redrice Ventures
- Reference Capital
- Reflex Capital
- Remiges Ventures
- Renaissance Capital Partners
- Research Corporation Technologies
- Resonance
- Revelation Partners
- Rhia Ventures
- Rhl Ventures
- Rhombuz VC
- Ride Home Fund
- Ridge Capital Partners
- RiverHead Capital
- Riverine Ventures
- RiverVest Venture Partners
- RM Global Partners
- Rock Creek Capital
- Rom Utrecht Region
- Route 66 Ventures
- RTW Investments
- RX3 Growth Partners
- Ryse Asset Management
S88
- Safar Partners
- SAGANA
- Sagitta Ventures
- Saisei Ventures
- Salem Partners
- Salt Ventures
- Sambrinvest
- Samsara BioCapital
- Sanderling / Sanderling Ventures
- Sanderling Ventures
- Sands Capital
- SANTÉ
- Sapien Ventures
- Sarsia Seed Management
- Satori Capital
- Saturn Partners
- SBI Securities
- Scale Capital
- Schooner Capital
- Schrödinger
- SCI Ventures
- Science Ventures A/S
- Scientia Ventures
- Scientific Health Development
- Scientifica Venture Capital
- Scion Life Sciences
- Scvc
- SDIC Fund Management
- SDIC Unity Capital
- Seae Ventures
- Section 32
- Sectoral Asset Management
- SeedToB Capital
- Seroba.
- Seventure Partners
- Sfpi-fpim
- SGI Venture Capital
- Shavit Capital
- Shepherd Ventures
- Shumway Capital
- Sierra Angels
- SightLine Partners
- Simpact Ventures
- Sirona Capital
- Sitra
- Sixty Degree Capital
- Skoll Foundation
- Skydeck Capital
- Skyline Investors
- Slate Mountains Capital
- SmiLe Incubator
- Smilegate Investment
- SNÖ Ventures
- Sofia Fund
- Sofilaro
- Sofinnova Investments
- Sofinnova Partners
- Solas BioVentures
- Solasta Ventures
- Sontag Family Trust
- Sopartec
- Sound Bioventures
- Southeast Minnesota Capital Fund
- Spectrum Financial (Omaha, NE)
- Split Rock Partners
- Sprim Global Investments
- Spring Mountain Capital
- Spur Capital Partners
- SR One Capital Management
- St. Cloud Capital
- Stafford Capital Partners
- Stand Together Ventures Lab
- StandUp Ventures
- Start Capital
- SteelSky Ventures
- SternAegis Ventures
- Stoic Venture Capital
- Sumitomo Corporation Equity Asia
- Sunstone Life Science Ventures
- Supernode Global
- Supernova Invest
- SV Health
- Sweater
- SwissHealth Ventures
- Symbiosis
- Symphony Ventures
- Syno Capital
- Synthesis Capital
T51
- T. Rowe Price
- Taiho Ventures
- Target ALS
- Techstart Ventures
- TechVision Fund
- TEDCO
- Teralys Capital
- Terra Vc
- TF Capital
- The Baupost Group
- The Cigna Group Ventures
- The Column Group
- The Craftory
- The Hive Southeast Asia
- The JumpFund
- The London Fund
- The Riverside Company
- The Scottish National Investment Bank
- The Sprout Fund
- The Trendlines Group
- The Vascular Group
- The Vertical Group
- The W Fund
- Theodorus Iii
- Third Rock Ventures
- Third Security
- Thoma Bravo
- Threshold Ventures
- Thuja Capital
- Time BioVentures
- Tin Alley Ventures
- TIO Bioventures
- Topspin Partners
- Touchdown Ventures
- Town Hall Ventures
- TPG Growth
- Tramway Venture Partners
- Trans-pacific Technology Fund (tptf)
- Transformation Capital
- Treo Ventures
- Triatomic Capital
- Triginta Capital
- Trihill Capital
- Trinity Innovation Bioventure Singapore
- Trinity Innovation Fund
- True.
- Turenne Groupe
- Turret Capital Management
- TVM Capital Life Science
- Two Bear Capital
- Two Sigma Ventures
U17
- UCB
- UF Innovate | Ventures
- Ulixes Capital
- Ulysses Diversified Holdings
- UNC Kenan-Flagler Family Enterprise Center
- Unconventional Ventures
- Underdog Labs
- Undeterred Capital
- UniQuest
- Uniseed
- University Growth Fund
- University of Nottingham
- University of Pennsylvania
- Unorthodox Ventures
- UPMC
- UPMC Enterprises
- USC Alfred E. Mann Institute (USC AMI)
V21
- V-Bio Ventures
- Valhalla Ventures
- Valiance Asset Management
- Vanderbilt University
- Vatera Healthcare Partners
- VCapital
- Ventana Capital Management
- Venture Investors Health Fund
- Versant Ventures
- Vi Partners
- Vib
- Vickers Venture Partners
- Viking Global Investors
- Virginia Active Angel Network
- Visionary Venture Fund
- VitaDAO
- Viva Ventures
- VIVES Partners
- Vivo Capital
- Vp Venture Partners
- Vulpes Ventures
W18
- W.I.N. Wilmington Investor Network
- WA4STEAM
- Washington Harbour Partners
- Washington Research Foundation
- Webrock Ventures
- Wellington Management
- Wellington Partners
- Welltech Ventures
- Werth Ventures
- Wexford Capital
- What If Ventures
- White Fund SA
- Wild Basin Investments
- Willett Advisors
- WindRose Health Investors
- WONIK Investment Partners
- Wu Capital
- Wyss Zurich
X4
- Xeraya Capital
- Xerys
- Xora Innovation
- Xprize
Y4
- York Capital Management
- Ysios Capital
- Yuanta Investment Korea (유안타인베스트먼트)
- Yukon Partners
Z4
- Zühlke Ventures
- Ziff Capital Partners
- Zürcher Kantonal Bank
- Zynext Ventures
#11
- 10x Value Partners
- 10X Venture Partners
- 1315 Capital
- 1843 Capital
- 24Haymarket
- 3 Rivers Capital
- 3Ã5 Partners
- 3CC | Third Culture Capital
- 3E Bioventures Capital
- 3h Health Investment
- 5AM Ventures
Frequently asked questions
How many Therapeutics investment firms are on RaiseHunt?
RaiseHunt lists 869 Therapeutics investment firms.
How many of them have a known portfolio?
862 of the 869 firms list at least one portfolio company, 8,149 known investments between them.
Who can I reach at these firms?
4,896 people working at them have a profile here, each with their role at the firm and whether an email address is on file.
Where are most Therapeutics investment firms based?
The largest concentrations are in San Francisco, New York and Boston.
What rounds do Therapeutics investment firms take part in?
Most list Seed and Series A among their stages.
How do I contact Therapeutics investment firms?
Every firm page shows whether an email address is on file, and the named contacts at that firm. The addresses themselves, along with AI matching and outreach, are in the RaiseHunt app.
Is the list of Therapeutics investment firms free to browse?
Yes. The directory and every firm page are free to read. Matching your own startup against them requires an account.
Do Therapeutics funds only back Therapeutics companies?
No. A focus area is a signal of interest, not a restriction. Firms usually list several, and the useful question is whether the existing portfolio looks like the kind of company you are building.
Who should I contact at Therapeutics investment firms?
A named partner or principal, not a general company address. Investment decisions sit with individual people, and a message that lands in a shared inbox usually stops there. Each fund page here lists the people we hold a profile for, with their role at the firm.
What does a portfolio tell me about a firm?
More than the description on its website. The companies a firm has already backed show the stage it really invests at, the kinds of business model it understands, and whether it has funded anything close to what you are building. Read the portfolio before you read the pitch page.
Do Therapeutics investment firms invest outside the sectors they list?
Often, though not far outside. Sector tags describe where a firm concentrates rather than a rule it follows, and companies that sit between two categories get funded all the time. The stronger signal is whether the firm has backed a business with a similar shape, whatever label it carried.
How many firms should I approach?
Far more than feels comfortable. Response rates on cold outreach are low even when the fit is good, so a short list of perfect names tends to stall. Build a long list, sort it by how well each firm matches what you are building, and work down it in batches rather than sending everything at once.
What should I have ready before reaching out to a firm?
A short deck, a one-paragraph description of what you do and who it is for, and a clear number for how much you are raising. Partners read the first two lines before they decide whether to open the deck, so those lines matter more than the rest of the document.
Data: RaiseHunt investor dataset · Snapshot 27 August 2026 · How this data is built · Report a correction or request removal